Background Statins may be protective in severe acute respiratory syndrome coronavirus 2
SARS-CoV-2 infection. The aim of the current study was to evaluate the effect of in-hospital …

Current data suggest that infection with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) causing corona virus disease-19 (COVID-19) seems to follow a more severe …

Background The efficacy of simvastatin in critically ill patients with coronavirus disease 2019
(Covid-19) is unclear. Methods In an ongoing international, multifactorial, adaptive platform …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes the
coronavirus disease 2019 (COVID-19) has infected millions of individuals and has claimed …

While most coronavirus disease 2019 (COVID-19) infections run a benign course with
recovery, the inexorable rise in case fatalities in several countries is grim testimony to the …

Background and aims Morbidity and mortality from coronavirus disease 2019 (COVID-19) is
higher among people with diabetes mellitus (DM), hypertension, and cardiovascular disease …

Center cardiologist Aakriti Gupta, MD, MS, has received a phone call from friends or
relatives in India who have COVID-19. They want to know whether they should start taking …

Purpose Considering the anti‐inflammatory effect of atorvastatin and the role of medical
comorbidities such as hypertension and coronary artery disease on the prognosis of the …

Patients with COVID-19 infection have an increased risk of cardiovascular complications
and thrombotic events. Statins are known for their pleiotropic anti-inflammatory …

The Coronavirus Disease 2019 (COVID-19) showed worse prognosis and higher mortality in
individuals with obesity. Dyslipidemia is a major link between obesity and COVID-19 …